Elaboration on the Early-Onset Hypothesis of Antipsychotic Drug Action: Treatment Response Trajectories
- 1 July 2010
- journal article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 68 (1), 86-92
- https://doi.org/10.1016/j.biopsych.2010.01.012
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Aventis
- BMS
- Eli Lilly
- Essex Pharma
- GlaxoSmithKline
- Janssen/Johnson and Johnson
- Lundbeck
- Pfizer
This publication has 29 references indexed in Scilit:
- Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of SchizophreniaNeuropsychopharmacology, 2009
- Definitions of response and remission in schizophrenia: recommendations for their use and their presentationActa Psychiatrica Scandinavica, 2008
- Dropout Rates in Randomized Clinical Trials of Antipsychotics: A Meta-analysis Comparing First- and Second-Generation Drugs and an Examination of the Role of Trial Design FeaturesSchizophrenia Bulletin, 2008
- Developmental Trajectories of Male Physical Violence and TheftArchives of General Psychiatry, 2007
- Linking the PANSS, BPRS, and CGI: Clinical ImplicationsNeuropsychopharmacology, 2006
- Clinical implications of Brief Psychiatric Rating Scale scoresThe British Journal of Psychiatry, 2005
- Early Prediction of Antipsychotic Response in SchizophreniaAmerican Journal of Psychiatry, 2003
- Are patients enrolled in first episode psychosis drug trials representative of patients treated in routine clinical practice?Schizophrenia Research, 2002
- Amisulpride vs. Risperidone in Chronic Schizophrenia Results of a 6-month Double-blind StudyNeuropsychopharmacology, 2002
- Adolescence-limited versus persistent delinquency: Extending Moffitt's hypothesis into adulthood.Journal of Abnormal Psychology, 2001